HOCPCA (3-hydroxycyclopent-1-enecarboxylic acid) drug for sale

본문 바로가기


Home > Product > HOCPCA (3-hydroxycyclopent-1-enecarboxylic acid) drug for sale
Product
HOCPCA (3-hydroxycyclopent-1-enecarboxylic acid) drug for sale
Posting date : May 08, 2018
Membership
Free Member Scince May 07, 2018
Min. Order Quantity
50
Supply Abillity
Yes
Port
150
Payment Terms
visa, mastercard, American express, bank transfer, bitcoin, litecoin, dash, zcash
Package
OEM
Keyword :
Category
Contact
Thomas Vendor
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
United States [US]
Brand Name
HOCPCA
HS-CODE
30-
Package & Delivery Lead Time
Package
OEM
Detailed Description
HOCPCA (3-hydroxycyclopent-1-enecarboxylic acid) is an antihypoxant, which has three types of effects: metabolic, neuroprotective and microcirculatory. HOCPCA increases the absorption and utilization of oxygen; Inositol phospho-oligosaccharides in the preparation positively influence the transport and utilization of glucose, which leads to an improvement in the energy metabolism of cells and a decrease in the formation of lactate in ischemic conditions. Several ways of implementing the neuroprotective mechanism of drug action are considered. HOCPCA interferes with the development of apoptosis induced by the beta-amyloid peptide (Ap25-35). HOCPCA modulates the activity of the nuclear factor kappa B (NF-kB), which plays an important role in the regulation of apoptosis and inflammation in the central and peripheral nervous system. Another mechanism of action is associated with the nuclear enzyme poly (ADP-ribose) -polymerase (PARP). PARP plays an important role in the detection and repair of damage to single-stranded DNA, but excessive activation of the enzyme can trigger cell death processes in conditions such as cerebrovascular disease and diabetic polyneuropathy. HOCPCA inhibits the activity of PARP, which leads to a functional and morphological improvement in the state of the central and peripheral nervous system. Positive effects of the drug HOCPCA, affecting the processes of microcirculation and the endothelium, are an increase in the rate of capillary blood flow, a decrease in the pericapillary zone, a decrease in the myogenic tone of precapillary arterioles and capillary sphincters, a decrease in the degree of arteriolovenous shunting blood flow with predominant circulation of blood in the capillary bed and stimulation of endothelial synthase function Nitric oxide, which affects the microcirculatory bed. In various studies it was found that the effect of the drug HOCPCA occurs no later than 30 minutes after its administration. The maximum effect is observed 3 hours after the parenteral and 2-6 hours after oral administration.
If you want to buy HOCPCA online please visit our online shop to place an order.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top